Medistim ASAMM

Medistim ASA

178.0NOKD
+6.0+3.49%
At close at 14:15 GMT
NOK
No trades
See on Supercharts
Next report date
May 9
Report period
Q1 2025
EPS estimate
1.43 NOK
Revenue estimate
‪150.00 M‬ NOK
Market capitalization
‪3.17 B‬NOK
‪103.83 M‬NOK
‪562.60 M‬NOK
‪15.97 M‬
Beta (1Y)
0.47

About MEDISTIM ASA


CEO
Kari Eian Krogstad
Headquarters
Oslo
Founded
1984
ISIN
NO0010159684
FIGI
BBG01L8XPCH9
Medistim ASA engages in the development, manufacture, and distribution of medical equipment and consumables. It operates through the Own Products and Third Party Products segments. The Own Products segment leases and sells equipment. The Third Party Products segment markets medical devices purchased from third party manufacturers located in Denmark and Norway. Its products include MiraQ Cardiac, MiraQ Vascular, MiraQ Ultimate, Imaging Probe, and Flow Probe. The company was founded by Kari Mette Tjolsen Pah on June 10, 1984 and is headquartered in Oslo, Norway.
Performance
‪10%‬
‪14%‬
‪18%‬
‪22%‬
‪26%‬
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
‪0.00‬
‪‪40.00 M‬‬
‪‪80.00 M‬‬
‪‪120.00 M‬‬
‪‪160.00 M‬‬
Revenue
Net income
Net margin %
Revenue to profit conversion
Revenue
COGS
Gross profit
Op expenses
Op income
Non-Op income/ expenses
Taxes & Other
Net income
‪0.00‬
‪‪40.00 M‬‬
‪‪80.00 M‬‬
‪‪120.00 M‬‬
‪‪160.00 M‬‬
Revenue
COGS
Gross profit
Expenses & adjustments
Net income
‪0.00‬
‪‪40.00 M‬‬
‪‪80.00 M‬‬
‪‪120.00 M‬‬
‪‪160.00 M‬‬
Debt level and coverage
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
‪0.00‬
‪‪50.00 M‬‬
‪‪100.00 M‬‬
‪‪150.00 M‬‬
‪‪200.00 M‬‬
Debt
Free cash flow
Cash & equivalents
Earnings
Next:May 9, 2025
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
‪0.00‬
‪0.50‬
‪1.00‬
‪1.50‬
‪2.00‬
Actual
Estimate

No news here

Looks like there's nothing to report right now

An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


Depending on the exchange, the stock ticker may vary. For instance, on AQUISEU exchange Medistim ASA stocks are traded under the ticker MEDIO.
We've gathered analysts' opinions on Medistim ASA future price: according to them, MEDIO price has a max estimate of 172.00 NOK and a min estimate of 172.00 NOK. Watch MEDIO chart and read a more detailed Medistim ASA stock forecast: see what analysts think of Medistim ASA and suggest that you do with its stocks.
MEDIO reached its all-time high on Feb 7, 2024 with the price of 220.0 NOK, and its all-time low was 132.0 NOK and was reached on Nov 15, 2024. View more price dynamics on MEDIO chart.
See other stocks reaching their highest and lowest prices.
Yes, you can track Medistim ASA financials in yearly and quarterly reports right on TradingView.
Medistim ASA is going to release the next earnings report on May 9, 2025. Keep track of upcoming events with our Earnings Calendar.
MEDIO earnings for the last quarter are 1.16 NOK per share, whereas the estimation was 1.32 NOK resulting in a −11.76% surprise. The estimated earnings for the next quarter are 1.43 NOK per share. See more details about Medistim ASA earnings.
Medistim ASA revenue for the last quarter amounts to ‪151.14 M‬ NOK, despite the estimated figure of ‪142.50 M‬ NOK. In the next quarter, revenue is expected to reach ‪150.00 M‬ NOK.
MEDIO net income for the last quarter is ‪21.30 M‬ NOK, while the quarter before that showed ‪23.43 M‬ NOK of net income which accounts for −9.07% change. Track more Medistim ASA financial stats to get the full picture.
Yes, MEDIO dividends are paid annually. The last dividend per share was 4.50 NOK. As of today, Dividend Yield (TTM)% is 2.59%. Tracking Medistim ASA dividends might help you take more informed decisions.
Medistim ASA dividend yield was 4.01% in 2024, and payout ratio reached 105.83%. The year before the numbers were 2.10% and 79.18% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Medistim ASA EBITDA is ‪155.59 M‬ NOK, and current EBITDA margin is 27.65%. See more stats in Medistim ASA financial statements.
Like other stocks, MEDIO shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Medistim ASA stock right from TradingView charts — choose your broker and connect to your account.